KomiPharm Ranks High in Search... Stock Price -1.15%
As of 10:30 AM on the 16th, Komipharm is trading at 12,850 KRW, down 1.15% from the previous day. This represents an 18.15% decline compared to October 6. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners have a tentative net purchase of 882 shares of Komipharm, while institutions have a net purchase of 3,000 shares. Over the past five days, individual investors have net purchased 106,022 shares, whereas foreigners and institutions have net sold 54,123 shares and 48,098 shares, respectively.
On October 14, Komipharm became an issue in the market with a sharp drop following the news of "Rejection of clinical trial application for COVID-19 treatment in Spain."
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
